Diabetes, Obesity & Metabolism
Nephroprotective Effects of the Dual GCGR/GLP-1R Agonist Survodutide in Hypertension-Accelerated Diabetic Kidney Disease
Experiments in miceSurvodutide
Papers by Max Hahn
2 results
- ADA Scientific Sessions 2026 Abstract
GUB-UCN2 as Monotherapy and in Combination with Semaglutide Increases Muscle Mass, Reduces Fat Mass, and Improves Metabolic Outcomes in Aged Diet-Induced Obese Rats
Experiments in animalsInterventions